Sakar Healthcare Ltd.
| BSE: 538377 | Sector: Health care |
| NSE: SAKAR | ISIN Code: INE732S01012 |
| BSE 05:30 | 01 Jan | Sakar Healthcare Ltd |
| NSE 15:42 | 30 Jul | 180.20 |
1.00 (0.56%) |
OPEN
181.30 |
HIGH
187.85 |
LOW
175.75 |
| OPEN | |
| PREVIOUS CLOSE | |
| VOLUME | |
| 52-Week high | 0.00 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 0 |
| Buy Price | |
| Buy Qty | |
| Sell Price | |
| Sell Qty |
Sakar Healthcare Ltd. (SAKAR) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Dr Reddy's Labs | 4712.70 | 41.65 | 0.89 | 13349.10 |
| Aurobindo Pharma | 916.50 | 8.30 | 0.91 | 13266.48 |
| Cipla | 920.30 | 38.00 | 4.31 | 12659.15 |
| Sun Pharma.Inds. | 774.00 | 70.75 | 10.06 | 12531.93 |
| Lupin | 1107.15 | 21.50 | 1.98 | 11055.93 |
| Apollo Hospitals | 4025.00 | -13.50 | -0.33 | 9794.50 |
| Cadila Health. | 585.95 | 14.05 | 2.46 | 7790.40 |
| Alkem Lab | 3460.00 | 128.55 | 3.86 | 7219.68 |
| Glenmark Pharma. | 607.60 | 16.00 | 2.70 | 6712.63 |
| Torrent Pharma. | 3069.70 | 32.65 | 1.08 | 6450.83 |
| Divi's Lab. | 4885.80 | 39.40 | 0.81 | 5310.57 |
| Alembic Pharma | 787.65 | 9.15 | 1.18 | 5051.44 |
| Laurus Labs | 640.65 | 36.00 | 5.95 | 4768.72 |
| Ipca Labs. | 2084.15 | -57.90 | -2.70 | 4337.82 |
| Abbott India | 18989.95 | 799.55 | 4.40 | 4310.02 |
| Glaxosmi. Pharma | 1609.00 | -17.90 | -1.10 | 3193.74 |
| Jubilant Pharmo | 686.10 | 1.05 | 0.15 | 3139.90 |
| Granules India | 379.35 | 7.90 | 2.13 | 3134.98 |
| Sanofi India | 8350.00 | 259.65 | 3.21 | 2901.90 |
| Ajanta Pharma | 2289.10 | -105.05 | -4.39 | 2718.59 |
Quick Links for Sakar Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
